These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27528761)

  • 41. Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors.
    Hawinkels LJ; de Vinuesa AG; Paauwe M; Kruithof-de Julio M; Wiercinska E; Pardali E; Mezzanotte L; Keereweer S; Braumuller TM; Heijkants RC; Jonkers J; Löwik CW; Goumans MJ; ten Hagen TL; ten Dijke P
    Clin Cancer Res; 2016 Jan; 22(1):96-106. PubMed ID: 26373572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.
    Wei Z; Salmon RM; Upton PD; Morrell NW; Li W
    J Biol Chem; 2014 Nov; 289(45):31150-9. PubMed ID: 25237187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioinformatic analysis of pathogenic missense mutations of activin receptor like kinase 1 ectodomain.
    Scotti C; Olivieri C; Boeri L; Canzonieri C; Ornati F; Buscarini E; Pagella F; Danesino C
    PLoS One; 2011; 6(10):e26431. PubMed ID: 22028876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
    Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
    Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
    Tu L; Desroches-Castan A; Mallet C; Guyon L; Cumont A; Phan C; Robert F; Thuillet R; Bordenave J; Sekine A; Huertas A; Ritvos O; Savale L; Feige JJ; Humbert M; Bailly S; Guignabert C
    Circ Res; 2019 Mar; 124(6):846-855. PubMed ID: 30636542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10.
    Ruiz S; Zhao H; Chandakkar P; Chatterjee PK; Papoin J; Blanc L; Metz CN; Campagne F; Marambaud P
    Sci Rep; 2016 Nov; 5():37366. PubMed ID: 27874028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
    Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
    EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome.
    Moore M; Ryzhov S; Sawyer DB; Gartner C; Vary CPH
    J Cell Signal; 2024; 5(3):122-142. PubMed ID: 39430425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence.
    Laux DW; Young S; Donovan JP; Mansfield CJ; Upton PD; Roman BL
    Development; 2013 Aug; 140(16):3403-12. PubMed ID: 23863480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
    Herrera B; van Dinther M; Ten Dijke P; Inman GJ
    Cancer Res; 2009 Dec; 69(24):9254-62. PubMed ID: 19996292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
    Chomette L; Hupkens E; Romitti M; Dewachter L; Vachiéry JL; Bailly S; Costagliola S; Smits G; Tillet E; Bondue A
    Am J Med Genet A; 2023 Aug; 191(8):2064-2073. PubMed ID: 37249087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
    Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K
    J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.
    Castonguay R; Werner ED; Matthews RG; Presman E; Mulivor AW; Solban N; Sako D; Pearsall RS; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2011 Aug; 286(34):30034-46. PubMed ID: 21737454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging role of bone morphogenetic proteins in angiogenesis.
    David L; Feige JJ; Bailly S
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):203-12. PubMed ID: 19502096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
    Adams SL; Benayoun L; Tilton K; Mellott TJ; Seshadri S; Blusztajn JK; Delalle I
    J Alzheimers Dis; 2018; 63(4):1433-1443. PubMed ID: 29843236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties.
    Mahlawat P; Ilangovan U; Biswas T; Sun LZ; Hinck AP
    Biochemistry; 2012 Aug; 51(32):6328-41. PubMed ID: 22799562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells.
    Cheng YW; Anzell AR; Morosky SA; Schwartze TA; Hinck CS; Hinck AP; Roman BL; Davidson LA
    Cells; 2024 Feb; 13(3):. PubMed ID: 38334677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.